Use of magnesium (Mg2+) for the preparation of a therapeutic composition for transfection of a polynucleotide into a cell and compositions useful in gene therapy
US6881724B2 · kind B2 · utility
0Cited by
12References
20Claims
0Family size
Assignees
Inventor
Key dates
| Filing date | Mar 28, 2002 |
| Grant date | Apr 19, 2005 |
| Priority date | — |
| Expiry date | Mar 28, 2022 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Described is the use of magnesium (Mg2+) for the preparation of a therapeutic composition for the introduction of a polynucleotide into a cell in vivo.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.